Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Favira vs Avigan in Healthy Male Subjects
NCT04400682Phase 1Completed
- Sponsor
- Novelfarma
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of favipiravir in influenza (2 arms), sponsored by Novelfarma. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started May 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04400682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400682.